The Registry
A trusted national picture of brain tumours in Aotearoa
New Zealand’s national brain tumour registry brings clinical information from across the motu into one secure, well-governed dataset, so clinicians, researchers and planners can see the whole picture, and patients and whānau can trust how their information is used.
Nationwide
Designed to include every hospital and health service that diagnoses or treats brain tumours in Aotearoa.
Ethics-approved
Operating under ethics approval, with privacy, consent and de-identification built into every step.
Clinically led
Shaped by neuro-oncology clinicians through NANOS and the hospital teams who care for patients every day.
Equity-focused
Committed to Māori data sovereignty and to understanding differences in access, treatment and outcomes.
What we collect
Core data, carefully defined
The Registry captures a focused set of clinical information for every eligible brain tumour diagnosis. Each data item is defined nationally, so information recorded in Whangārei means exactly the same thing as information recorded in Invercargill.
Identifying details are stored separately from clinical data and are never included in reports.
Diagnosis & pathology
Tumour type, grade and location, molecular markers, and the date and method of diagnosis.
Treatment pathways
Surgery, radiotherapy, chemotherapy and supportive care, including timing and the treating service.
Outcomes & follow-up
Progression, recurrence and survival, recorded consistently so that trends can be measured over time.
Demographics & equity
Age, sex, ethnicity and region, so the Registry can show where care is working well and where gaps exist.
How it works
From diagnosis to insight in four steps
The Registry is designed to fit around existing clinical work, adding as little extra effort as possible for busy teams.
Notification
Treating hospitals notify the Registry of a new brain tumour diagnosis through their existing clinical systems.
Data capture
Clinical teams record the core dataset using a shared national data dictionary, with support from Registry staff.
Quality & governance
Records are checked, coded and de-identified, and every use of the data is reviewed by the governance group.
Insight & access
Aggregated findings are published openly, and approved researchers can apply for secure access to detailed data.
Data & governance
Your information, protected
Trust is the foundation of the Registry. Governance, privacy and Māori data sovereignty are designed in from the start, not added later.
Common questions
Who can access Registry data?
Aggregated, de-identified findings are published for everyone. Detailed data is only available to approved researchers and clinicians through a formal application reviewed by the governance group.
How is my privacy protected?
Identifying details are stored separately from clinical information, every access is logged and audited, and published reports use methods that prevent individuals being identified, including the suppression of small numbers.
Can I choose not to be included?
Yes. Patients and whānau can ask for their information to be removed, or not used for research, at any time by contacting the Registry. This has no effect on the care you receive.
Who governs the Registry?
A governance group with clinical, research, Māori and consumer representation oversees the Registry, supported by the Centre for Brain Research at the University of Auckland.
Who's involved
A national brain tumour registry built with clinical and research partners
University of Auckland
Centre for Brain Research
NANOS
NZ Aotearoa Neuro Oncology Society
Clinical Partners
Hospitals & health services
Research Community
Universities & institutes
Ready to take part?
Whether you treat patients, lead research, or want to understand how your information is used, we would like to hear from you.